Creative Ev To Sales from 2010 to 2024

CELZ Stock  USD 2.31  0.12  4.94%   
Creative Medical EV To Sales yearly trend continues to be fairly stable with very little volatility. EV To Sales is likely to outpace its year average in 2024. EV To Sales is the Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue. View All Fundamentals
 
EV To Sales  
First Reported
2010-12-31
Previous Quarter
337.39005778
Current Value
354.26
Quarterly Volatility
216.0847811
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Creative Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Creative Medical's main balance sheet or income statement drivers, such as Selling General Administrative of 3.2 M, Other Operating Expenses of 5.9 M or Total Operating Expenses of 5.8 M, as well as many indicators such as Price To Sales Ratio of 757, Dividend Yield of 0.0039 or PTB Ratio of 0.66. Creative financial statements analysis is a perfect complement when working with Creative Medical Valuation or Volatility modules.
  
Check out the analysis of Creative Medical Correlation against competitors.

Latest Creative Medical's Ev To Sales Growth Pattern

Below is the plot of the Ev To Sales of Creative Medical Technology over the last few years. It is the Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue. Creative Medical's EV To Sales historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Creative Medical's overall financial position and show how it may be relating to other accounts over time.
Ev To Sales10 Years Trend
Slightly volatile
   Ev To Sales   
       Timeline  

Creative Ev To Sales Regression Statistics

Arithmetic Mean268.42
Geometric Mean203.10
Coefficient Of Variation80.50
Mean Deviation189.64
Median426.85
Standard Deviation216.08
Sample Variance46,693
Range587
R-Value(0.61)
Mean Square Error31,703
R-Squared0.37
Significance0.02
Slope(29.37)
Total Sum of Squares653,697

Creative Ev To Sales History

2024 354.26
2023 337.39
2022 -160.49
2021 -56.44
2020 53.16
2019 8.7
2018 74.84

About Creative Medical Financial Statements

Creative Medical investors use historical fundamental indicators, such as Creative Medical's Ev To Sales, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Creative Medical. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
EV To Sales 337.39  354.26 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Creative Stock Analysis

When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.